TYRA-430
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TYRA-430, covering 2025-11-20 to 2025-11-20. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations [Phase 1]